Wednesday December 19, 2018

Eat Just a Handful of Nuts Every Day to Cut Heart and Cancer Risk, says a Recent Study

Nuts and peanuts are high in fibre, magnesium, and polyunsaturated fats which can reduce cholesterol levels

0
//
Representational image. Pixabay
Republish
Reprint

London, December 5, 2016: Eating at least 20 gram of nuts a day — equivalent to a handful — can reduce the risk of a wide range of diseases including heart disease and cancer, new research has found.

Handful of nuts daily can cut people’s risk of coronary heart disease by nearly 30 per cent, their risk of cancer by 15 per cent, and their risk of premature death by 22 per cent, the study said.

NewsGram brings to you current foreign news from all over the world.

The study included all kinds of tree nuts, such as hazel nuts and walnuts, and also peanuts — which are actually legumes.

The results – published in the journal BMC Medicine – were in general similar whether total nut intake, tree nuts or peanuts were analysed.

What makes nuts so potentially beneficial is their nutritional value, said study co-author Dagfinn Aune from Imperial College London.

“Nuts and peanuts are high in fibre, magnesium, and polyunsaturated fats — nutrients that are beneficial for cutting cardiovascular disease risk and which can reduce cholesterol levels,” Aune said.

NewsGram brings to you top news around the world today.

“Some nuts, particularly walnuts and pecan nuts are also high in antioxidants, which can fight oxidative stress and possibly reduce cancer risk,” Aune explained.

The research team analysed 29 published studies from around the world that involved up to 819,000 participants, including more than 12,000 cases of coronary heart disease, 9,000 cases of stroke, 18,000 cases of cardiovascular disease and cancer, and more than 85,000 deaths.

While there was some variation between the populations that were studied, such as between men and women, people living in different regions, or people with different risk factors, the researchers found that nut consumption was associated with a reduction in disease risk across most of them.

Check out NewsGram for latest international news updates.

“Even though nuts are quite high in fat, they are also high in fibre and protein, and there is some evidence that suggests nuts might actually reduce your risk of obesity over time,” Aune said.

The study also found that if people consumed on average more than 20 gram of nuts per day, there was little evidence of further improvement in health outcomes. (IANS)

Click here for reuse options!
Copyright 2016 NewsGram

Next Story

New Drug to Give Hopes to Bone Marrow Cancer Patients

It reduced the risk of progression or death by more than 50 per cent in both groups

0
Cancer
Cancer Ribbon. Pixabay

A therapeutic drug has been found to improve outcomes and survival rates for patients with a serious type of bone marrow cancer.

In a clinical trial by researchers at Newcastle University in Britain, patients with newly diagnosed myeloma were treated with a drug called lenalidomide.

The results, published in the journal The Lancet Oncology, showed an improvement for those who received lenalidomide drug, compared to those not receiving it.

“This is a major breakthrough as it shows that the long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy,” said Professor Graham Jackson from the Northern Institute for Cancer Research at Newcastle.

Myeloma is a cancer of the plasma cells and it can affect several areas of the body, such as the spine, skull, pelvis and ribs. Current treatment usually involves chemotherapy and a stem-cell transplant.

cancer
New drug offers hope for bone marrow cancer patients. Pixabay

“It is a huge step and, importantly, identifies that for younger patients lenalidomide improves their overall survival for this difficult-to-treat bone marrow cancer,” Jackson said.

“Our research highlights that lenalidomide should be considered for newly diagnosed patients following stem-cell transplantation,” he added.

As part of the study, a total of 1,137 newly diagnosed patients were randomly assigned to lenalidomide maintenance therapy and 834 patients to observation – this was after they completed their initial treatment.

Also Read- Narendra Modi Accuses Congress of Aiding Those Who Want to Weaken Army

The results show that lenalidomide can prolong the average remission time by more than two years in younger patients and by well over a year in older, less fit patients.

It reduced the risk of progression or death by more than 50 per cent in both groups. (IANS)